Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer - Wikidata - wikimedia - TriplyDB

Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer

Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer

http://www.wikidata.org/entity/Q35982771

about

A review of malaria vaccine clinical projects based on the WHO rainbow table Acquired immunity to malaria Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes Vaccines and immunization strategies for dengue prevention A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines.The IC(50) of anti-Pfs25 antibody in membrane-feeding assay varies among species.Population biology of malaria within the mosquito: density-dependent processes and potential implications for transmission-blocking interventions.Bacterial superglue enables easy development of efficient virus-like particle based vaccines.Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice.Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention.Comparison of protective immune responses to apicomplexan parasites Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses.Plant expression and characterization of the transmission-blocking vaccine candidate PfGAP50.A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation Experience and challenges from clinical trials with malaria vaccines in Africa Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders.Costs of crowding for the transmission of malaria parasites Plasmodium vivax: who cares?Malaria vaccines and their potential role in the elimination of malaria.Immunisation against a serine protease inhibitor reduces intensity of Plasmodium berghei infection in mosquitoes.What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future.Evaluation of two lead malaria transmission blocking vaccine candidate antibodies in natural parasite-vector combinations.Heat-precipitation allows the efficient purification of a functional plant-derived malaria transmission-blocking vaccine candidate fusion protein.Naturally Acquired Antibody Responses to a Synthetic Malaria Antigen AS202.11.Efficacy model for mosquito stage transmission blocking vaccines for malaria.Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.Optimization of a multi-stage, multi-subunit malaria vaccine candidate for the production in Pichia pastoris by the identification and removal of protease cleavage sites.Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity.Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines.Infection of Anopheles aquasalis from symptomatic and asymptomatic Plasmodium vivax infections in Manaus, western Brazilian Amazon.

P2860

Q21034112-B81F75D0-0B0E-4441-93E7-D35D25AF0D34 Q24651173-1635E948-755C-4777-BDE4-00802F0A71EC Q24705181-A775DB1A-A73E-4AA3-81F9-4F033B0CF4FF Q28077521-034E8494-9B55-42CB-93CC-14433A10C958 Q28740771-3E251C2A-53D3-4CF5-A0F4-0BBB08984F54 Q28744581-70D1F09A-BD5A-4C82-96A0-E6AC8325F09D Q30390705-B22DC88C-397F-484D-91D8-4D1007A9F1E9 Q33350210-01EFB675-5B56-478E-8CC4-75A955D18FBF Q33812439-437DF128-2FF7-4FCF-9384-73C247C38668 Q33892507-9160CEC3-4E71-471A-AE6C-0D8AE96C226D Q34332247-CA02B0A0-F703-4EF1-8714-F8B8BB995239 Q34523734-0CD5254A-89AC-4930-B569-D5F4873A3225 Q34618434-629C0BC1-9CD2-47F6-8DE8-B46BB7E56A4D Q35048518-EDD3AFAC-12D3-41D5-B467-60EB962162B3 Q35097106-8746CC66-F295-4362-B9C0-6EC383EBDB49 Q35173273-99877663-378D-4EF5-AADA-AA9637856605 Q35439931-1EDB5A90-71A3-4FAC-8A21-84E39E97262B Q35718341-3BB3BAF9-55F5-4BD0-BCEA-0F7362C457C4 Q35841913-8860F1D9-BF65-4B5C-B4F1-C8DF09DFD910 Q35857500-327E042B-7334-4310-8F44-D427D29810FD Q35887438-29DEA6A5-A2D4-49C9-BA64-80FAD0512603 Q36428352-B1F840B1-5EF5-40C0-BFD3-ACF83EC1113E Q36690983-1F214D1C-9EF3-4463-A031-3E67E2F69BB2 Q36718066-FA67799A-861A-4AFE-A5B7-5F6099D7D933 Q36935100-75DC864B-7E56-4763-B459-DF1DB317992A Q37018632-26D05FF6-CA67-424B-90E3-FBEB636F47F3 Q37018637-B827153E-7812-47A7-B442-A7C6994E02B5 Q37176727-165E9D7F-38B0-4020-87B6-709A6B566953 Q37638131-87725C14-1570-49F0-97CE-16AA6170D098 Q38614539-7D8B84D8-AA36-4164-9D41-8DEECEDC8932 Q40004898-084DB1F7-8723-4336-B548-AA63DED6D002 Q40103373-8330F859-5A4B-40DE-8AAF-45B3866C0F62 Q41525140-74A5D497-FF96-4596-B1B5-7550D8C89D79 Q43375963-F3B248EA-57B6-4C12-8367-2C280D0D678D Q44140071-FD622663-C72F-4633-B423-7890312D7B7A Q44169982-F1281610-26D7-49E4-84F0-64E7CE85CF02 Q44941813-4C6F40D3-56C4-4DFC-8C05-4ABD5159B1CA Q47711225-3685D57B-BB29-4C54-9FB2-CC135C852341 Q49730085-00D1BE73-88CD-457C-BEB5-4A9A0D38A62D Q54220803-7576838F-3E35-4F0F-B19F-98E1E4E9AC16

P2860

Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer

http://www.wikidata.org/entity/Q35982771

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Transmission-blocking activity ...... ble function of antibody titer

@ast

Transmission-blocking activity ...... ble function of antibody titer

@en

type

label

Transmission-blocking activity ...... ble function of antibody titer

@ast

Transmission-blocking activity ...... ble function of antibody titer

@en

prefLabel

Transmission-blocking activity ...... ble function of antibody titer

@ast

Transmission-blocking activity ...... ble function of antibody titer

@en

P1433

Q35982771-7CA76222-1CBF-435A-861A-66C4783D5A71

P1476

Q35982771-684E2FC1-D77F-4783-93BD-0A6FFEEC46D5

P2093

Q35982771-36407E93-0522-423D-AB8F-45A38A8880C9

Q35982771-B825D940-1007-4220-A687-B51C07CBF18F

P2860

Q35982771-08500D76-D195-43BA-A378-39FEB30F9738

Q35982771-203CFD6E-E8DD-4E6A-A47F-C0DD96B8A9BA

Q35982771-250E7199-5697-426F-A4CA-FDB2DD53C267

Q35982771-28BD8C54-40A6-4759-8BD3-66D7EA46A1F2

Q35982771-2C44DF13-4ED6-4DDF-8BB9-9EAB8EA6E399

Q35982771-2D4F508B-1181-40F9-B9ED-8E8B375810A2

Q35982771-2EC2154E-FF94-4C71-86D8-932757CCFD4B

Q35982771-344B7763-7608-40FF-9E4E-FB0F9FB641AC

Q35982771-34D6A47B-A097-424F-8EE8-56C69616260E

Q35982771-377D6CED-1E3A-473C-A3DA-D48013D07310

P2888

Q35982771-9D748D9C-BFED-4817-B9E9-C7193C24995A

P304

Q35982771-5D2E08EA-B340-40A6-9632-67621AC8ABB9

P31

Q35982771-F1B888A7-5154-4ECF-97C3-A25F134B5EF2

P356

Q35982771-C8DE4D98-6205-4E8C-A5BF-7BF064362E1D

P478

Q35982771-AD4D5F55-B5DA-4ED1-BBDF-08E9E53E9381

P50

Q35982771-2753E832-723A-4BAC-A562-ED8652D30E16

Q35982771-57E7FDA1-8F5B-4AD1-A630-19248378A77F

Q35982771-74A46406-4EAB-48E1-9C5C-6CD0756BE275

Q35982771-84DF3718-99E8-4A48-93A8-FE4F9BEDF6A5

P577

Q35982771-F4B7698C-D7D3-4257-8D49-13E4C764E82E

P5875

Q35982771-BDBDE7DF-FD82-40B2-AE3A-526F36552344

P6179

Q35982771-076019F8-6E82-4872-A0AB-25C32C403425

P698

Q35982771-ACE4D2BB-A78A-4BD8-AC47-108146111640

P921

Q35982771-4DA5887C-88E0-407B-9354-9254CCD3E882

Q35982771-85947F2C-0604-4770-8B0F-BA4A33E821A2

Q35982771-9257A3B5-C3A3-41A5-B082-5A0296E83142

P932

Q35982771-D8383E63-F0B2-48EF-B29C-DFC2C7634BC1

P356

1475-2875-6-107

P1433

Malaria Journal

P1476

Transmission-blocking activity ...... ble function of antibody titer

@en

P2093

David B Keister

http://www.w3.org/2001/XMLSchema#string

Olga V Muratova

http://www.w3.org/2001/XMLSchema#string

P2860

Malaria in 2002

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data.

Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies

Malaria transmission-blocking vaccines--how can their development be supported?

Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes.

Specificity of the protective antibody response to apical membrane antigen 1

Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli

Child mortality and malaria transmission intensity in Africa.

P2888

1475-2875-6-107

P304

107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-6-107

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Jetsumon Sattabongkot

P577

2007-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6153680

http://www.w3.org/2001/XMLSchema#string

P6179

1051058716

http://www.w3.org/2001/XMLSchema#string

P698

17686163

http://www.w3.org/2001/XMLSchema#string

P921

malaria transmission

P932

1971714

http://www.w3.org/2001/XMLSchema#string